Venetsanopoulou I Aliki (Michalis P Migkos, Aliki I Venetsanopoulou, A I Venetsanopoulou, Aliki Venetsanopoulou)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

Top Venues

Rheumatology international

Expert review of clinical immunology

Journal of clinical medicine

Scandinavian journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Melina Yerolatsite, Nanteznta Torounidou, Venetsanopoulou I Aliki, George Zarkavelis, Davide Mauri, Paraskevi Vasileios Voulgari
Digital ischemia: a rare immune-related adverse event of immune checkpoint inhibitors-case report and review of the literature. Rheumatology international (2024)
Venetsanopoulou I Aliki, Nikoletta E Anagnostou, Zoi Tziortzioti, Anastasia Zikou, Loukas G Astrakas, Maria I Argyropoulou, Paraskevi Vasileios Voulgari
"Long-term MRI findings in Ankylosing spondylitis patients treated with TNF inhibitors for a decade". Rheumatology international (2024)
Venetsanopoulou I Aliki, Ioanna Katsigianni, Elpida Skouvaklidou, Periklis Vounotrypidis, Paraskevi Vasileios Voulgari
Uncommon Coexistence of Systemic Lupus Erythematosus and Psoriatic Arthritis: A Case-Based Review. Current rheumatology reviews (2024)
Venetsanopoulou I Aliki, Natasa Kalpourtzi, Yannis Alamanos, Magda Gavana, Apostolos Vantarakis, Christos S Hadjichristodoulou, Varvara A Mouchtouri, Grigoris Chlouverakis, Grigorios Trypsanis, Alexandros A Drosos, Giota Touloumi, Paraskevi Vasileios Voulgari, null null
Prevalence of rheumatoid arthritis in Greece: results from the national health examination survey EMENO. Rheumatology international (2023)
Venetsanopoulou I Aliki, Yannis Alamanos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Decline in the incidence of rheumatoid arthritis in north-western Greece in 1980-2019. Rheumatology international (2023)
Venetsanopoulou I Aliki, Paraskevi Vasileios Voulgari, Alexandros A Drosos
TNFα inhibitor biosimilar associated with polychondritis. A case-based review. Rheumatology international (2023)
Venetsanopoulou I Aliki, Yannis Alamanos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Epidemiology of rheumatoid arthritis: genetic and environmental influences. Expert review of clinical immunology 18 (9) (2022)
Venetsanopoulou I Aliki, Yannis Alamanos, Anastasia Skalkou, Paraskevi Vasileios Voulgari, Alexandros A Drosos
The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre. Scandinavian journal of rheumatology (2022)
George Markousis-Mavrogenis, Maria Bonou, Vasiliki Vartela, Genovefa Kolovou, Venetsanopoulou I Aliki, Theodora Markatseli, Anastasia Skalkou, Zoi Tziortzioti, Paraskevi Voulgari, Sophie I Mavrogeni
Cardiovascular Magnetic Resonance Detects Inflammatory Cardiomyopathy in Symptomatic Patients with Inflammatory Joint Diseases and a Normal Routine Workup. Journal of clinical medicine 11 (5) (2022)
Paraskevi Vasileios Voulgari, Venetsanopoulou I Aliki, Pieta Antigone, Tziortzioti Zoi, Zikou K Anastasia, Alexandros A Drosos
Orbital myositis in systemic lupus erythematosus: a case-based review. Rheumatology international 42 (8) (2022)
Venetsanopoulou I Aliki, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis. Expert review of clinical immunology 18 (5) (2022)
Evangelia Argyriou, Adrianos Nezos, Petros Roussos, Venetsanopoulou I Aliki, Michael Voulgarelis, Kyriaki Boki, Athanasios G Tzioufas, Haralampos M Moutsopoulos, Clio P Mavragani
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome. Journal of clinical medicine 10 (4) (2021)
Venetsanopoulou I Aliki, Theodora E Markatseli, Chrisoula Iliou, Zoi Tziortzioti, Maria I Argyropoulou, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Pleural effusion in psoriatic arthritis patients: a case series and review of the literature. Clinical rheumatology 40 (11) (2021)
Venetsanopoulou I Aliki, Euripidis Kaltsonoudis, Alexandros A Drosos, Vassiliki Drossou, Panagiota G Karagianni, Athanasios Kavvadias, Paraskevi Vasileios Voulgari, Alexandros A Drosos
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience. Rheumatology international 41 (5) (2021)
Antigone Pieta, A Zioga, Anastasia Skalkou, Venetsanopoulou I Aliki, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Fibroblastic rheumatism: an uncommon arthritis. A case-based review. Rheumatology international (2021)
Venetsanopoulou I Aliki, Alexandros A Drosos, Paraskevi Vasileios Voulgari, Alexandros A Drosos
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatology international 40 (8) (2020)